GLP-1 Medications Online: How to Get a Prescription, Costs, and What to Expect

You can get GLP-1 medications online through licensed telehealth providers. After a health questionnaire and clinician review, eligible patients may receive a prescription for FDA-approved options like Wegovy (semaglutide) or Zepbound (tirzepatide), or a compounded option from a licensed 503A pharmacy when appropriate. Shipping timing varies by pharmacy and state rules [1][2][7].

Quick facts: getting GLP-1 medications online

GLP-1 medications online are prescription treatments, not over-the-counter products. A legitimate online path includes identity checks, medical history, BMI review, contraindication screening, and a prescription only if a licensed clinician decides the benefits may outweigh the risks [1][2][3].

• Online prescribing can be appropriate when the provider follows state telehealth rules and uses licensed clinicians.
• FDA-approved chronic weight-management options include Wegovy (semaglutide), Zepbound (tirzepatide), and Saxenda (liraglutide) [1][2][3].
• Ozempic (semaglutide), Rybelsus (oral semaglutide), and Mounjaro (tirzepatide) are FDA-approved for type 2 diabetes, not chronic weight management [4][5][6].
• Most weight-management labels include BMI cutoffs of 30, or 27 with at least one weight-related condition such as hypertension, dyslipidemia, or type 2 diabetes [1][2][3].
• Side effects are common, especially stomach-related symptoms, and serious warnings include thyroid C-cell tumors, pancreatitis, gallbladder disease, kidney injury, and low blood sugar risk when combined with insulin or sulfonylureas [1][2][3].

What are GLP-1 medications?

GLP-1 receptor agonist medications are prescription drugs that copy or enhance signals from gut hormones involved in appetite, blood sugar, and digestion. For weight management, the key FDA-approved injectable options are Wegovy, Zepbound, and Saxenda, while other GLP-1 drugs are approved for type 2 diabetes [1][2][3][4][5][6].

How GLP-1 receptor agonists work

GLP-1 receptor agonists act on receptors in the pancreas, gut, and brain. They can increase glucose-dependent insulin release, reduce glucagon, slow stomach emptying, and affect appetite signals [1][4][6]. These effects may support weight loss, but they also explain common side effects like nausea, vomiting, diarrhea, constipation, and feeling full quickly [1][2][3].

GLP-1 vs GLP-1/GIP dual agonists

Semaglutide, sold as Wegovy, Ozempic, and Rybelsus, is a GLP-1 receptor agonist; semaglutide may also be available as a compounded formulation through licensed 503A pharmacies when prescribed for an individual patient, but compounded semaglutide is not FDA-approved [1][4][6][7]. Tirzepatide, sold as Zepbound and Mounjaro, is a GLP-1/GIP dual receptor agonist; compounded tirzepatide is also not FDA-approved [2][5][7].

Which GLP-1 medications can I get online?

GLP-1 medications available through online care may include FDA-approved brand-name drugs, diabetes-only GLP-1s when appropriate, and non-FDA-approved compounded options. The right option depends on diagnosis, BMI, medical history, insurance, state rules, and supply [1][2][7].

FDA-approved brand-name GLP-1s: Wegovy, Zepbound, Saxenda, Ozempic, and Mounjaro

Wegovy (semaglutide, a GLP-1 receptor agonist) is FDA-approved for chronic weight management in adults with BMI 30 or higher, or BMI 27 or higher with at least one weight-related condition; it also has a cardiovascular risk-reduction indication in certain adults [1]. Zepbound (tirzepatide, a GLP-1/GIP dual receptor agonist) is FDA-approved for chronic weight management using similar BMI criteria, and Saxenda (liraglutide, a GLP-1 receptor agonist) is also FDA-approved for chronic weight management [2][3].

Ozempic (semaglutide) and Mounjaro (tirzepatide) are FDA-approved for type 2 diabetes, not chronic weight management, even though they affect appetite and weight in clinical studies [4][5]. If an online service offers them for a non-labeled use, that should be framed as off-label clinical decision-making, not a guaranteed or routine weight-loss path.

Oral GLP-1s: Wegovy pill, Rybelsus, and orforglipron

Rybelsus (oral semaglutide) is FDA-approved for adults with type 2 diabetes, not chronic weight management [6]. Oral semaglutide for obesity and orforglipron, sometimes discussed online with the proposed brand name Foundayo, have been studied for weight management, but orforglipron is not FDA-approved for weight loss based on currently available FDA labeling [12]. These oral options may cause stomach side effects similar to injectable incretin drugs, and long-term labeling decisions depend on FDA review [6][12].

Compounded semaglutide and tirzepatide from 503A pharmacies

Compounded semaglutide and compounded tirzepatide are not FDA-approved medications. A 503A pharmacy is a state-licensed compounding pharmacy that prepares a medication for an individual patient after receiving a valid prescription; FDA says compounded drugs are not reviewed for safety, effectiveness, or quality before marketing in the same way FDA-approved drugs are [7].

For some patients, compounded GLP-1s may be considered when a clinician believes a compounded prescription is appropriate. Safety still matters: ask whether the pharmacy is licensed, whether it uses third-party potency and sterility testing when applicable, and whether the prescription uses semaglutide or tirzepatide base rather than a salt form not evaluated in the FDA-approved products [7].

Can I really get a GLP-1 prescription online?

Yes, online GLP-1 prescriptions can be legitimate when they come from a licensed clinician after a real medical review. A safe online process screens for BMI, weight-related conditions, pregnancy status, medication interactions, thyroid cancer history, pancreatitis history, gallbladder disease, kidney problems, and diabetes medications that may raise low-blood-sugar risk [1][2][3].

How the telehealth visit works

1. 1You complete a health questionnaire with height, weight, medical history, medications, allergies, and goals.
2. 2A licensed clinician reviews your information and may request labs, a blood pressure reading, or a video visit.
3. 3If treatment is appropriate, the clinician writes a prescription for an FDA-approved medication or, when clinically appropriate, a compounded medication from a licensed pharmacy.
4. 4The pharmacy fills the prescription and provides medication instructions, safety information, and follow-up needs.
5. 5Follow-up visits track side effects, weight response, dose tolerability, and whether treatment should continue.

What labs or medical history you may need

A clinician may ask about A1C, kidney function, liver history, pregnancy plans, gallbladder symptoms, pancreatitis, thyroid nodules, family history of medullary thyroid carcinoma, and current diabetes medications [1][2][3]. Labs are not always the same for every person, but safety screening is important because GLP-1s can affect digestion, hydration, glucose levels, and gallbladder risk [1][2].

Who is eligible: BMI thresholds and health conditions

For chronic weight management, Wegovy, Zepbound, and Saxenda labels include adults with BMI 30 or higher, or BMI 27 or higher with at least one weight-related condition [1][2][3]. Eligibility for online prescribing also depends on state of residence, contraindications, pregnancy status, medication access, and clinician judgment.

How much do GLP-1 medications cost online?

GLP-1 medication cost online can range from a covered insurance copay to more than $1,000 per month for some brand-name cash-pay prescriptions. Compounded options may cost less, but they are not FDA-approved and should be evaluated for pharmacy quality, prescription oversight, and follow-up care [7][13][14].

Brand-name pricing with and without insurance

Without insurance, brand-name GLP-1 prices can be high. Novo Nordisk has listed Wegovy at about $1,349.02 per 28-day package, and Eli Lilly has listed Zepbound at about $1,086.37 per month, though real pharmacy prices can vary [13][14]. Side effects and contraindications are the same regardless of whether a person pays cash or uses insurance [1][2].

Manufacturer savings cards: NovoCare, LillyDirect, and similar programs

Manufacturer savings programs may lower out-of-pocket costs for eligible patients, often with limits based on insurance type, diagnosis, and plan coverage [13][14]. These programs do not replace a clinical review, and they do not change boxed warnings, stomach side effects, or contraindications [1][2].

Compounded semaglutide and tirzepatide pricing

Compounded semaglutide and compounded tirzepatide are often offered as cash-pay programs. They are not FDA-approved, so patients should ask about pharmacy licensing, the active ingredient, sterility practices for injectables, potency testing, adverse-event reporting, and follow-up care [7].

Prior authorization: what to expect

Prior authorization means your insurer asks the clinician to document why the medication is medically necessary. Plans may request BMI, weight-related conditions, prior treatment attempts, diabetes status, or proof that the drug matches the plan’s covered indication [1][2][4][5].

How to get GLP-1 medications online through Chia

Chia is one option among licensed telehealth providers for people seeking a clinician-reviewed path to compounded GLP-1 treatment. The process includes an online intake, eligibility review, prescription decision by a licensed clinician when appropriate, and fulfillment through licensed 503A pharmacy partners; compounded medications are not FDA-approved and require the same serious safety screening as other GLP-1 options [1][2][7].

What side effects and safety issues should I know about?

GLP-1 side effects are often stomach-related, but serious risks can happen. The FDA labels for Wegovy, Zepbound, and Saxenda include boxed warnings about thyroid C-cell tumors and say these drugs are contraindicated in people with a personal or family history of medullary thyroid carcinoma, or with Multiple Endocrine Neoplasia syndrome type 2 [1][2][3].

Common side effects

• Nausea
• Vomiting
• Diarrhea
• Constipation
• Abdominal pain
• Indigestion or reflux
• Headache or fatigue
• Decreased appetite

In clinical trials, stomach side effects were among the most common reasons people stopped treatment [1][2][8][9]. Tell a clinician promptly about severe vomiting, dehydration, persistent abdominal pain, fainting, or symptoms of low blood sugar, especially if you also use insulin or a sulfonylurea [1][2][4][5].

Serious warnings: thyroid, pancreatitis, gallbladder, kidney, and mood symptoms

FDA labels warn about pancreatitis, gallbladder disease, acute kidney injury, increased heart rate, low blood sugar risk with certain diabetes drugs, and possible suicidal thoughts or behavior monitoring for some weight-management products [1][2][3]. These risks are uncommon compared with nausea, but they are important reasons to use a licensed clinician rather than buying medication from an unverified source.

Who should not take GLP-1s

Wegovy, Zepbound, and Saxenda should not be used by people with a personal or family history of medullary thyroid carcinoma or MEN 2, and they are not recommended during pregnancy [1][2][3]. People with pancreatitis history, gallbladder disease, severe stomach-emptying problems, kidney disease, or complex diabetes regimens need careful review before any prescription decision [1][2][4][5].

How much weight can I expect to lose on a GLP-1?

GLP-1 weight loss varies a lot by medication, dose studied, adherence, side effects, nutrition, activity, sleep, and follow-up support. Trials show average weight loss, not a guarantee, and those benefits must be balanced against nausea, vomiting, gallbladder events, pancreatitis warnings, and thyroid boxed warnings [1][2][8][9].

Clinical trial results by medication

In the STEP 1 trial, adults without diabetes received semaglutide 2.4 mg once weekly plus lifestyle intervention, and the semaglutide group had a mean body-weight change of -14.9% at 68 weeks versus -2.4% with placebo; individual results varied, and gastrointestinal side effects were common [8]. This dose is a study-attributed and FDA-label dose, not a dosing instruction for the reader [1][8].

In the SURMOUNT-1 trial, adults with obesity or overweight without diabetes received tirzepatide 5 mg, 10 mg, or 15 mg once weekly, and mean body-weight changes at 72 weeks were -15.0%, -19.5%, and -20.9% versus -3.1% with placebo; individual results varied, and nausea, diarrhea, and constipation were common [9]. These are trial doses, not personal dosing advice [2][9].

In the SCALE Obesity and Prediabetes trial, adults received liraglutide 3.0 mg daily with lifestyle counseling, and mean weight loss at 56 weeks was 8.4 kg versus 2.8 kg with placebo; individual results varied, and nausea and diarrhea were more common with liraglutide [10]. This is a study-attributed and FDA-label dose, not a dosing recommendation [3][10].

The role of diet, exercise, and behavioral support

The major weight-management trials paired medication with lifestyle support, such as reduced-calorie eating plans, physical activity guidance, or counseling [8][9][10]. Medication can help some people eat less by reducing hunger and slowing stomach emptying, but nutrition, activity, sleep, and follow-up care still affect results and side effects [1][2][8][9].

How do I choose between online GLP-1 providers?

Choose an online GLP-1 provider that uses licensed clinicians, clear safety screening, transparent pharmacy information, and follow-up care. A safe provider should explain FDA-approved and compounded options clearly, including that compounded GLP-1 medications are not FDA-approved [7].

Signs of a legitimate telehealth provider

• Requires a real medical history, medication list, height, weight, and contraindication screening.
• Uses licensed clinicians who can prescribe in your state.
• Explains FDA approval status for each medication.
• Provides clear side-effect guidance and follow-up plans.
• Names the dispensing pharmacy or explains how prescriptions are sent.
• For compounded medications, uses licensed 503A pharmacies and can answer quality questions.

Red flags to avoid

• No clinician review before payment or shipment.
• Promises a specific amount of weight loss.
• Calls compounded medications FDA-approved.
• Sells research chemicals or peptide products without prescriptions.
• Does not screen for MTC, MEN 2, pregnancy, pancreatitis, gallbladder disease, or diabetes medication risks.
• Will not identify the pharmacy or provide basic safety information.

Questions to ask before signing up

• Am I being evaluated for an FDA-approved medication, a compounded medication, or both?
• Which clinician will review my information, and are they licensed in my state?
• Which pharmacy fills the prescription?
• What happens if I have nausea, vomiting, abdominal pain, or signs of low blood sugar?
• Do you help with prior authorization if I use insurance?
• What is included in the monthly cost: visits, medication, labs, shipping, or follow-up?

Frequently asked questions

Keep reading

GLP-1 Weight Loss

How to Get a GLP-1 Prescription Online: Options, Costs, and Eligibility

Weight Loss

How to Get Weight Loss Medication: Eligibility, Options, and Costs

GLP-1 Weight Loss

How to Get a GLP-1 Prescription Online: What to Expect, Who Qualifies, and What It Costs